Home › Funds › Aequim Alternative Investments LP › LGND

Aequim Alternative Investments LP position in LGND

LIGAND PHARMACEUTICALS INC · Health Care

Aequim Alternative Investments LP reported holding 12,500,000 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$21.0M, representing 0.42% of its reported portfolio and ranking #45 among its reported holdings. Aequim Alternative Investments LP first reported this position in Q3 2026.

Latest position (Q3 2026)12.50M sh
Reported value held$21.01M
Portfolio Weight0.42%
First reportedQ3 2026
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Aequim Alternative Investments LP's LGND position evolved

Aequim Alternative Investments LP first disclosed a stake in LGND in Q3 2026 at 12,500,000 shares (US$21.0M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 12.50M $21.01M New

About LGND and 13F data

LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 52 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$139.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LGND

All LGND fund holders →

FAQ

How long has Aequim Alternative Investments LP held LGND?

Aequim Alternative Investments LP has disclosed LGND holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Aequim Alternative Investments LP's current position in LGND?

As of Q3 2026, Aequim Alternative Investments LP holds 12.50M shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $21.01M, representing 0.42% of its reported portfolio and ranking #45.

Has Aequim Alternative Investments LP been buying or selling LGND?

In the latest 13F filing (Q3 2026), Aequim Alternative Investments LP newly opened its position in LGND.

Which other funds hold LGND?

Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.